Global Overactive Bladder Drug Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Overactive Bladder Drug market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Overactive Bladder Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overactive Bladder Drug development in United States, Europe and China.
    
    The key players covered in this study
        Astellas Pharma, Inc. (Japan)
        Pfizer, Inc. (U.S.)
        Teva Pharmaceutical Industries Limited (Israel)
        Allergan, Plc (Ireland)
        Medtronic plc (Ireland)
        Mylan N.V. (U.S.)
        Endo International plc (Ireland)
        Hisamitsu Pharmaceutical Co., Inc. (Japan)
        Sanofi (France)
        Apotex, Inc. (Canada)
        Cogentix Medical, Inc. (U.S.)
        Aurobindo Pharma Limited (India)
    
    Market segment by Type, the product can be split into
        Anticholinergics
        Solifenacin
        Oxybutynin
        Darifenacin
        Fesoterodine
        Tolterodine
        Trospium
        Others
    
    Market segment by Application, split into
        Idiopathic Bladder Overactivity
        Neurogenic Bladder Overactivity
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Overactive Bladder Drug status, future forecast, growth opportunity, key market and key players.
        To present the Overactive Bladder Drug development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Overactive Bladder Drug are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Overactive Bladder Drug Market Size Growth Rate by Type (2013-2025)
            1.4.2 Anticholinergics
            1.4.3 Solifenacin
            1.4.4 Oxybutynin
            1.4.5 Darifenacin
            1.4.6 Fesoterodine
            1.4.7 Tolterodine
            1.4.8 Trospium
            1.4.9 Others
        1.5 Market by Application
            1.5.1 Global Overactive Bladder Drug Market Share by Application (2013-2025)
            1.5.2 Idiopathic Bladder Overactivity
            1.5.3 Neurogenic Bladder Overactivity
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Overactive Bladder Drug Market Size
        2.2 Overactive Bladder Drug Growth Trends by Regions
            2.2.1 Overactive Bladder Drug Market Size by Regions (2013-2025)
            2.2.2 Overactive Bladder Drug Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Overactive Bladder Drug Market Size by Manufacturers
            3.1.1 Global Overactive Bladder Drug Revenue by Manufacturers (2013-2018)
            3.1.2 Global Overactive Bladder Drug Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Overactive Bladder Drug Market Concentration Ratio (CR5 and HHI)
        3.2 Overactive Bladder Drug Key Players Head office and Area Served
        3.3 Key Players Overactive Bladder Drug Product/Solution/Service
        3.4 Date of Enter into Overactive Bladder Drug Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Overactive Bladder Drug Market Size by Type (2013-2018)
        4.2 Global Overactive Bladder Drug Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Overactive Bladder Drug Market Size (2013-2018)
        5.2 Overactive Bladder Drug Key Players in United States
        5.3 United States Overactive Bladder Drug Market Size by Type
        5.4 United States Overactive Bladder Drug Market Size by Application
    
    6 Europe
        6.1 Europe Overactive Bladder Drug Market Size (2013-2018)
        6.2 Overactive Bladder Drug Key Players in Europe
        6.3 Europe Overactive Bladder Drug Market Size by Type
        6.4 Europe Overactive Bladder Drug Market Size by Application
    
    7 China
        7.1 China Overactive Bladder Drug Market Size (2013-2018)
        7.2 Overactive Bladder Drug Key Players in China
        7.3 China Overactive Bladder Drug Market Size by Type
        7.4 China Overactive Bladder Drug Market Size by Application
    
    8 Japan
        8.1 Japan Overactive Bladder Drug Market Size (2013-2018)
        8.2 Overactive Bladder Drug Key Players in Japan
        8.3 Japan Overactive Bladder Drug Market Size by Type
        8.4 Japan Overactive Bladder Drug Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Overactive Bladder Drug Market Size (2013-2018)
        9.2 Overactive Bladder Drug Key Players in Southeast Asia
        9.3 Southeast Asia Overactive Bladder Drug Market Size by Type
        9.4 Southeast Asia Overactive Bladder Drug Market Size by Application
    
    10 India
        10.1 India Overactive Bladder Drug Market Size (2013-2018)
        10.2 Overactive Bladder Drug Key Players in India
        10.3 India Overactive Bladder Drug Market Size by Type
        10.4 India Overactive Bladder Drug Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Overactive Bladder Drug Market Size (2013-2018)
        11.2 Overactive Bladder Drug Key Players in Central & South America
        11.3 Central & South America Overactive Bladder Drug Market Size by Type
        11.4 Central & South America Overactive Bladder Drug Market Size by Application
    
    12 International Players Profiles
        12.1 Astellas Pharma, Inc. (Japan)
            12.1.1 Astellas Pharma, Inc. (Japan) Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Overactive Bladder Drug Introduction
            12.1.4 Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.1.5 Astellas Pharma, Inc. (Japan) Recent Development
        12.2 Pfizer, Inc. (U.S.)
            12.2.1 Pfizer, Inc. (U.S.) Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Overactive Bladder Drug Introduction
            12.2.4 Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.2.5 Pfizer, Inc. (U.S.) Recent Development
        12.3 Teva Pharmaceutical Industries Limited (Israel)
            12.3.1 Teva Pharmaceutical Industries Limited (Israel) Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Overactive Bladder Drug Introduction
            12.3.4 Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.3.5 Teva Pharmaceutical Industries Limited (Israel) Recent Development
        12.4 Allergan, Plc (Ireland)
            12.4.1 Allergan, Plc (Ireland) Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Overactive Bladder Drug Introduction
            12.4.4 Allergan, Plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.4.5 Allergan, Plc (Ireland) Recent Development
        12.5 Medtronic plc (Ireland)
            12.5.1 Medtronic plc (Ireland) Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Overactive Bladder Drug Introduction
            12.5.4 Medtronic plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.5.5 Medtronic plc (Ireland) Recent Development
        12.6 Mylan N.V. (U.S.)
            12.6.1 Mylan N.V. (U.S.) Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Overactive Bladder Drug Introduction
            12.6.4 Mylan N.V. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.6.5 Mylan N.V. (U.S.) Recent Development
        12.7 Endo International plc (Ireland)
            12.7.1 Endo International plc (Ireland) Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Overactive Bladder Drug Introduction
            12.7.4 Endo International plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.7.5 Endo International plc (Ireland) Recent Development
        12.8 Hisamitsu Pharmaceutical Co., Inc. (Japan)
            12.8.1 Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Overactive Bladder Drug Introduction
            12.8.4 Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.8.5 Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development
        12.9 Sanofi (France)
            12.9.1 Sanofi (France) Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Overactive Bladder Drug Introduction
            12.9.4 Sanofi (France) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.9.5 Sanofi (France) Recent Development
        12.10 Apotex, Inc. (Canada)
            12.10.1 Apotex, Inc. (Canada) Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Overactive Bladder Drug Introduction
            12.10.4 Apotex, Inc. (Canada) Revenue in Overactive Bladder Drug Business (2013-2018)
            12.10.5 Apotex, Inc. (Canada) Recent Development
        12.11 Cogentix Medical, Inc. (U.S.)
        12.12 Aurobindo Pharma Limited (India)
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Overactive Bladder Drug Key Market Segments
        Table Key Players Overactive Bladder Drug Covered
        Table Global Overactive Bladder Drug Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Overactive Bladder Drug Market Size Market Share by Type 2013-2025
        Figure Anticholinergics Figures
        Table Key Players of Anticholinergics
        Figure Solifenacin Figures
        Table Key Players of Solifenacin
        Figure Oxybutynin Figures
        Table Key Players of Oxybutynin
        Figure Darifenacin Figures
        Table Key Players of Darifenacin
        Figure Fesoterodine Figures
        Table Key Players of Fesoterodine
        Figure Tolterodine Figures
        Table Key Players of Tolterodine
        Figure Trospium Figures
        Table Key Players of Trospium
        Figure Others Figures
        Table Key Players of Others
        Table Global Overactive Bladder Drug Market Size Growth by Application 2013-2025 (Million US$)
        Figure Idiopathic Bladder Overactivity Case Studies
        Figure Neurogenic Bladder Overactivity Case Studies
        Figure Overactive Bladder Drug Report Years Considered
        Table Global Overactive Bladder Drug Market Size 2013-2025 (Million US$)
        Figure Global Overactive Bladder Drug Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Overactive Bladder Drug Market Size by Regions 2013-2025 (Million US$)
        Table Global Overactive Bladder Drug Market Size by Regions 2013-2018 (Million US$)
        Table Global Overactive Bladder Drug Market Share by Regions 2013-2018
        Figure Global Overactive Bladder Drug Market Share by Regions 2013-2018
        Figure Global Overactive Bladder Drug Market Share by Regions 2018
        Table Market Top Trends
        Table Global Overactive Bladder Drug Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Overactive Bladder Drug Market Share by Manufacturers (2013-2018)
        Figure Global Overactive Bladder Drug Market Share by Manufacturers in 2018
        Table Global Overactive Bladder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Overactive Bladder Drug Product/Solution/Service
        Table Date of Enter into Overactive Bladder Drug Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table Global Overactive Bladder Drug Market Size Share by Type (2013-2018)
        Figure Global Overactive Bladder Drug Market Size Market Share by Type (2013-2018)
        Table Global Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table Global Overactive Bladder Drug Market Size Share by Application (2013-2018)
        Figure Global Overactive Bladder Drug Market Size Market Share by Application (2013-2018)
        Figure Global Overactive Bladder Drug Revenue Market Share by Application in 2017
        Figure United States Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table United States Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table United States Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table United States Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table United States Overactive Bladder Drug Market Share by Type (2013-2018)
        Table United States Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table United States Overactive Bladder Drug Market Share by Application (2013-2018)
        Figure Europe Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table Europe Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table Europe Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table Europe Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table Europe Overactive Bladder Drug Market Share by Type (2013-2018)
        Table Europe Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table Europe Overactive Bladder Drug Market Share by Application (2013-2018)
        Figure China Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table China Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table China Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table China Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table China Overactive Bladder Drug Market Share by Type (2013-2018)
        Table China Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table China Overactive Bladder Drug Market Share by Application (2013-2018)
        Figure Japan Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table Japan Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table Japan Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table Japan Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table Japan Overactive Bladder Drug Market Share by Type (2013-2018)
        Table Japan Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table Japan Overactive Bladder Drug Market Share by Application (2013-2018)
        Figure Southeast Asia Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table Southeast Asia Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Overactive Bladder Drug Market Share by Type (2013-2018)
        Table Southeast Asia Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Overactive Bladder Drug Market Share by Application (2013-2018)
        Figure India Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table India Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table India Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table India Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table India Overactive Bladder Drug Market Share by Type (2013-2018)
        Table India Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table India Overactive Bladder Drug Market Share by Application (2013-2018)
        Figure Central & South America Overactive Bladder Drug Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Overactive Bladder Drug Market Share (2017-2018)
        Table Central & South America Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Overactive Bladder Drug Market Share by Type (2013-2018)
        Table Central & South America Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Overactive Bladder Drug Market Share by Application (2013-2018)
        Table Astellas Pharma, Inc. (Japan) Company Details
        Table Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018) (Million US$)
        Figure Astellas Pharma, Inc. (Japan) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Astellas Pharma, Inc. (Japan) Recent Development
        Table Pfizer, Inc. (U.S.) Company Details
        Table Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Pfizer, Inc. (U.S.) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Pfizer, Inc. (U.S.) Recent Development
        Table Teva Pharmaceutical Industries Limited (Israel) Company Details
        Table Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Teva Pharmaceutical Industries Limited (Israel) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Teva Pharmaceutical Industries Limited (Israel) Recent Development
        Table Allergan, Plc (Ireland) Company Details
        Table Allergan, Plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Allergan, Plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Allergan, Plc (Ireland) Recent Development
        Table Medtronic plc (Ireland) Company Details
        Table Medtronic plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Medtronic plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Medtronic plc (Ireland) Recent Development
        Table Mylan N.V. (U.S.) Company Details
        Table Mylan N.V. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Mylan N.V. (U.S.) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Mylan N.V. (U.S.) Recent Development
        Table Endo International plc (Ireland) Company Details
        Table Endo International plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Endo International plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Endo International plc (Ireland) Recent Development
        Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details
        Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development
        Table Sanofi (France) Company Details
        Table Sanofi (France) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Sanofi (France) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Sanofi (France) Recent Development
        Table Apotex, Inc. (Canada) Company Details
        Table Apotex, Inc. (Canada) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)
        Figure Apotex, Inc. (Canada) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)
        Table Apotex, Inc. (Canada) Recent Development
        Table Cogentix Medical, Inc. (U.S.) Company Details
        Table Aurobindo Pharma Limited (India) Company Details
        Table Global Overactive Bladder Drug Market Size by Regions (Million US$) 2018-2025
        Figure Global Overactive Bladder Drug Market Size Share by Regions (2018-2025)
        Figure Global Overactive Bladder Drug Market Size Share by Regions in 2025
        Figure United States Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Figure China Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Figure India Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)
        Table Global Overactive Bladder Drug Market Size by Product (2018-2025) (Million US$)
        Figure Global Overactive Bladder Drug Market Size by Product (2018-2025)
        Figure Global Overactive Bladder Drug Market Size by Product in 2025
        Table Global Overactive Bladder Drug Market Size by Application (2018-2025) (Million US$)
        Figure Global Overactive Bladder Drug Market Size by Application (2018-2025)
        Figure Global Overactive Bladder Drug Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources